Author pages are created from data sourced from our academic publisher partnerships and public sources.
Orthotopic liver transplantation for alcoholic liver disease
Alcohol abuse is the most common cause of end‐stage liver disease in the United States, but many transplant centers are unwilling to accept alcoholic patients because of their supposed potential for… Expand
[Evaluation of the effectiveness of prostacyclin in the treatment of thrombosis of the central retinal vein using a double-blind method].
The patients were divided by chance into 2 groups: the first one (15 persons) was given a natrium salt of prostacyclin (Epoprostenol Wellcome or Chinoin) in a dose of 5 mg/kg/min. intravenously by an… Expand
Plasma antioxidant potency and serum copper levels in atherosclerosis.
- A. Dembińska-kieć, A. Zmuda, +4 authors E. Kostka-Trabka
- Chemistry, Medicine
- Polish journal of pharmacology and pharmacy
- 1 March 1985
Blood plasma of patients with arteriosclerosis obliterans and diabetes showed a higher antioxidant potency as compared with plasma of healthy volunteers. Serum copper level in those patients was also… Expand
[Administration of prostacyclin in sudden deafness. Evaluation with the double blind method].
- E. Olszewski, E. Kostka-Trąbka, +7 authors M. Slawinski
- Otolaryngologia polska = The Polish…
Prostacyclin (PGI2) connects all the pharmacologic properties of drugs being used till now in sudden deafness. 30 patients with sensori-neural sudden deafness were treated by prostacyclin and placebo… Expand
Prostacyclin in patients with peptic gastric ulcers--a placebo controlled study.
- A. Dembińska-Kiéc, E. Kostka-Trąbka, +6 authors H. Gärtner
- 1 December 1986
A double-blind study on prostacyclin (5 ng/kg/min infused i.v. for 5 hrs per day during 6 consecutive days) for the treatment of peptic gastric ulcers was carried out in thirty patients (15… Expand
[Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans].
- A. Dembińska-Kiéc, E. Kostka-Trąbka, +7 authors H. Czarnecka
- Fortschritte der Medizin
- 10 July 1989
In a pilot study the therapeutic effect of 2 x 500 mg etofibrate (Lipo Merz retard) on lipids and lipoproteins, fibrinolytic activity and clinical parameters was studied for four weeks in… Expand
[Use of nitrendipine in treating patients with obliterative atherosclerosis of arteries in the lower extremities].
- L. Grodzińska, E. Kostka-Trąbka, M. Basista, K. Bieroń, M. Sławiński, E. Telesz
- Polski tygodnik lekarski
- 5 August 1991
Twenty patients with obliterative atherosclerosis in the lower extremities arteries (Fontaine's stage II) were treated with nitrendipine (Bayotensin) given in the dose of 20 mg daily for 6 weeks.… Expand
[Use of etofibrate in the treatment of patients with hyperlipidemia and arteriosclerosis obliterans of the legs].
[Kallikrein in the treatment of patients with obliterative atherosclerosis of the lower limbs and its mechanism of action].
Kallikrein (Padutin-Depot) was administered to 20 patients with obliterative atherosclerosis of the lower limbs of the II degree (19 patients) and IV degree (1 patient). The drug was given in the… Expand
[Use of prostacyclin in patients with stomach ulcer in a double-blind clinical trial].